Glenmark Life Sciences Limited (GLS.NS) NSE
1,086.00
+1.65(+0.15%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Glenmark Life Sciences Limited
Address
Glenmark House
Mumbai, 400099
India
Phone
91 21 8923 4456
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2014
First IPO Date
August 06, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Yasir Yusufali Rawjee | Chief Executive Officer, MD & Director | 272.35M | 1965 |
| Sumantra Mitra | Senior Vice President & Head of Human Resources | 18.2M | N/A |
| Vinod Naik | Group Vice President, Head of Technical Operations & Whole Time Director | 56.56M | N/A |
| Mathew George | Senior Vice President & Head of Regulatory Affairs | 0 | N/A |
| Rudalf Corriea | Company Secretary & Compliance Officer | 0 | N/A |
| Tushar Mistry | Senior Vice President & Chief Financial Officer | 0 | N/A |
| Soumi Rao | General Manager of Corporate Communications | 0 | N/A |
| Navin Kumar Agrawal | Vice President & Head of Corporate Quality | 0 | N/A |
Description
Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin for diabetes; and Etoricoxib and Lornoxicam for pain management. It also provides Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas. In addition, the company offers contract development and manufacturing services to a range of multinational pharmaceutical and specialty pharmaceutical companies. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited.
